Phenotypic and molecular characterization of a non-lethal, hamster-viscerotropic strain of yellow fever virus

Virus Research

Volumn 110, Issue 1-2, 2005, Pages 65-71

  McArthur, Monica A ^a   Xiao, Shu Yuan ^a,b   Barrett, Alan D T ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Asibi P7b virus; Hamster model; Viscerotropism; Yellow fever virus

Indexed keywords

AMINO ACID; ENVELOPE PROTEIN;

ARTICLE; COMPARATIVE STUDY; GENE SEQUENCE; HAMSTER; HISTOPATHOLOGY; LIVER; MICROSCOPY; MOLECULAR BIOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPLEEN; VIRUS ISOLATION; VIRUS STRAIN; WILD TYPE; YELLOW FEVER FLAVIVIRUS;

ANIMALIA; CRICETINAE; PRIMATES; YELLOW FEVER VIRUS;

EID: 17444417139     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2005.01.004     Document Type: Article

References (30)

1. S.L. Allison, J. Schalich, K. Stiasny, C.W. Mandl, and F.X. Heinz Mutational evidence for an internal fusion peptide in flavivirus envelope protein E J. Virol. 75 9 2001 4268 4275
2. S. Bhardwaj, M. Holbrook, R.E. Shope, A.D.T. Barrett, and S.J. Watowich Biophysical characterization and vector specific antagonist activity of domain III of the Tick-Borne flavivirus envelope protein J. Virol. 75 8 2001 4002 4007
3. D. Cecilia, and E.A. Gould Nucleotide changes responsible for loss of neuroinvasiveness in Japanese Encephalitis virus neutralization-resistant mutants Virology 181 1991 70 77
4. Y. Chen, T. Maguire, R.E. Hileman, J.R. Fromm, J.D. Esko, R.J. Linhardt, and R.M. Marks Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate Nat. Med. 3 8 1997 866 871
5. W.D. Crill, and J.T. Roehrig Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells J. Virol. 75 16 2001 7769 7773
6. G. Findlay, and L. Clarke The susceptibility of the hedgehog to yellow fever I. The viscerotropic virus Trans. R. Soc. Trop. Med. Hyg. XXVIII 2 1934 193 200
7. G.F. Gao, M.H. Hussain, H.W. Reid, and E.A. Gould Identification of naturally occuring monoclonal antibody escape variants of louping ill virus J. Gen. Virol. 75 1994 609 614
8. C.S. Hahn, J.M. Dalrymple, J.H. Strauss, and C.M. Rice Comparison of the virulent Asibi strain of yellow fever with the 17D vaccine strain derived from it Proc. Natl. Acad. Sci. U.S.A. 84 1987 2019 2023
9. H. Hasegawa, M. Yoshida, T. Shiosaka, S. Fujita, and Y. Kobayashi Mutations in the envelope protein of Japanese encephalitis virus affect entry into cultured cells and virulence in mice Virology 191 1992 158 165
10. H. Holzmann, F.X. Heinz, C.W. Mandl, F. Guirakhoo, and C. Kunz A single amino acid substitution in envelope protein E of tick-borne encephalitis virus leads to attenuation in the mouse model J. Virol. 64 10 1990 5156 5159
11. R.J. Hurrelbrink, and P.C. McMinn Attenuation of Murray Valley encephalitis virus by site-directed mutagenesis of the hinge and putative receptor-binding regions of the envelope protein J. Virol. 75 16 2001 7692 7702
12. Jennings, A.D., Gibson, C.A., Miller B.R., Mathews, J.H., Mitchell, C.J., Roehrig, J.T., Wood, D.J., Taffs, F., Sil, B.K., Whitby, S.N., Whitby, J.E., Monath, T.P., Minor, P.D., Sanders, P.G., Barrett, A.D.T., 1994. Analysis of a yellow fever virus isolate from a fatal case of vaccine-associated human encephalitis. J. Infect. Dis. 169, 512-518.
13. A.D. Jennings, J.E. Whitby, P.D. Minor, and A.D.T. Barrett Comparison of the nucleotide and deduced amino acid sequences of the envelope protein genes of the wild-type French viscerotropic strain of yellow fever virus and the live vaccine strain, French neurotropic vaccine, derived from it Virology 192 1993 692 695
14. W.R. Jiang, A. Lowe, S. Higgs, H. Reid, and E.A. Gould Single amino acid codon changes detected in louping ill virus antibody-resistant mutants with reduced neurovirulence J. Gen. Virol. 74 1993 931 935
15. E. Lee, and M. Lobigs Mechanisms of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus J. Virol. 76 10 2002 4901 4911
16. M. Lobigs, R. Usha, A. Nestorowicz, I.D. Marshall, R.C. Weir, and L. Dalgarno Host cell selection of Murray Valley encephalitis virus variants altered at an RGD sequence in the envelope protein and in mouse virulence Virology 176 1990 587 595
17. C.W. Mandl, S.L. Allison, H. Holzmann, T. Meixner, and F.X. Heinz Attenuation of tick-borne encephalitis virus by structure-based site-specific mutagenesis of a putative flavivirus receptor binding site J. Virol. 74 20 2000 9601 9609
18. M.A. McArthur, M.T. Suderman, J.P. Mutebi, S.Y. Xiao, and A.D. Barrett Molecular characterization of a hamster viscerotropic strain of yellow fever virus J. Virol. 77 2 2003 1462 1468
19. T.P. Monath, K. Brinker, F. Chandler, G. Kemp, and C. Cropp Pathophysiologic correlations in a rhesis monkey model of yellow fever with special observations on the acute necrosis of B cell areas of lymphoid tissues Am. J. Trop. Med. Hyg. 30 2 1981 431 443
20. F.A. Rey, F.X. Heinz, C. Mandl, C. Kunz, and S.C. Harrison The envelope glycoprotein from tick-borne encephalitis virus at 2 angstrom resolution Nature 375 1995 291 298
21. C.M. Rice, E.M. Lenches, S.R. Eddy, S.J. Shih, R.L. Sheets, and J.H. Strauss Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution Science 229 1985 726 733
22. K.D. Ryman, T.N. Ledger, R.C. Weir, J.J. Schlessinger, and A.D.T. Barrett Yellow fever virus envelope protein has two discrete type-specific neutralizing epitopes J. Gen. Virol. 78 1997 1353 1356
23. K.D. Ryman, H. Xie, T.N. Ledger, G.A. Campbell, and A.D.T. Barrett Antigenic variants of yellow fever virus with an altered neurovirulence phenotype in mice Virology 230 1997 376 380
24. G.K. Strode Yellow fever 1951 McGraw-Hill New York
25. R.B. Tesh, H. Guzman, A.P. da Rosa, P.F. Vasconcelos, L.B. Dias, J.E. Bunnell, H. Zhang, and S.Y. Xiao Experimental yellow fever virus infection in the Golden Hamster (Mesocricetus auratus). I. Virologic, biochemical, and immunologic studies J. Infect. Dis. 183 10 2001 1431 1436
26. P. Thullier, C. Demangel, H. Bedouelle, F. Megret, A. Jouan, V. Deubel, J.C. Mazie, and P. Lafaye Mapping of a dengue virus neutralizing epitope critical for the infectivity of all serotypes: insight into the neutralization mechanism J. Gen. Virol. 82 2001 1885 1892
27. R.G. van der Most, J. Corver, and J.H. Strauss Mutagenesis of the RGD motif in the yellow fever virus 17D envelope protein Virology 265 1999 83 95
28. T.D. Volkova, M.F. Vorovitch, V.T. Ivanov, A.V. Timofeev, and O.M. Volpina A monoclonal antibody that recognizes the predicted tick-borne encephalitis virus E protein fusion sequence blocks fusion Arch. Virol. 144 1999 1035 1039
29. S.Y. Xiao, H. Guzman, A.P. da Rosa, H.B. Zhu, and R.B. Tesh Alteration of clinical outcome and histopathology of yellow fever virus infection in a hamster model by previous infection with heterologous flaviviruses Am. J. Trop. Med. Hyg. 68 6 2003 695 703
30. S.Y. Xiao, H. Zhang, H. Guzman, and R.B. Tesh Experimental yellow fever virus infection in the Golden hamster (Mesocricetus auratus). II. Pathology J. Infect. Dis. 183 10 2001 1437 1444